Provider Profile

Thumbnail
Saint Luke’s Care Member

Provider Profile

Ruby O Meierotto, MD

Radiology
Call to make an appointment 816-347-5068

Education

Medical School
University of Texas Health Science Center, San Antonio, TX
Internship
Internal Medicine, University of Kansas Medical Center, Kansas City, KS
Residency
Rad/Diagnostic, University of Kansas Medical Center, Kansas City, KS
Fellowship
Rad/Diagnostic, Univ of Southern CA - LAC & USC Medical Cntr, Los Angeles, CA

Board Certifications

  • American Board of Radiology [Diagnostic Radiology]

Academic Titles

  • Associate Clinical Professor, University of Missouri–Kansas City School of Medicine

Clinical Interests

  • breast imaging
  • breast biopsies
  • mammography
  • breast wire localizations
  • breast ultrasound

Biography

Dr. Meierotto was Board Certified by the American Board of Radiology in June 2007. She completed a Women’s Imaging Fellowship at the University of Southern California in Los Angeles, California. Her radiology residency and internal medicine internship was at the University of Kansas Medical Center in Kansas City, Kansas. She completed her medical training at the University of Texas Medical School in San Antonio, Texas.

Saint Luke's News

KCTV: Saint Luke's High-Risk Breast Clinic
Saint Luke's High-Risk Breast Clinic allows women with a higher chance of developing breast cancer to be closely monitored. Dr. Ruby Meierotto shared tips for reducing your risk on Better Kansas City.

Accepted Insurances

  • Aetna Better Health/KanCare (KS Medicaid)
  • Aetna Choice POS II Aexcel Local
  • Aetna Choice POS II Local
  • Aetna Elect Choice POS
  • Aetna Federal Employees Health Benefit Plan HMO
  • Aetna First Health Network (excluding limited benefit plans)
  • Aetna HMO
  • Aetna HMO Local
  • Aetna Managed Choice POS
  • Aetna Medicare Plan (Medicare Advantage HMO, PPO)
  • Aetna Missouri Preferred
  • Aetna Open Choice PPO
  • Aetna Select HMO
  • Aetna Select Local HMO
  • Aetna Signature Administrators (ASA) HMO, POS, PPO
  • Aetna UAW Retiree Medical Benefits Trust (Medicare Advantage HMO, PPO)
  • Aetna Workers Comp
  • Aetna/Coventry Advantra Freedom Medicare Advantage PPO
  • Aetna/Coventry Advantra Freedom Plus Medicare Advantage PPO
  • Aetna/Coventry Advantra HMO
  • Aetna/Coventry Advantra Total Care Medicare Advantage PPO
  • BCBS of Kansas (call provider)
  • BCBS of Kansas Blue Choice Preferred Care Blue PPO
  • BCBS of Kansas City Blue Select Plus (UCMO and City of KCMO)
  • BCBS of Kansas City Federal PPO
  • BCBS of Kansas City Freedom Network PPO
  • BCBS of Kansas City Freedom Network Select PPO
  • BCBS of Kansas City Preferred Care
  • BCBS of Kansas City Preferred Care Blue
  • BCBS of Kansas City Traditional
  • BCBS of Kansas Federal
  • BCBS of Kansas Traditional
  • BCBS of Michigan Medicare Advantage PPO
  • Blue KC Medicare Advantage HMO
  • Blue KC Medicare Advantage PPO
  • Century Health Solutions (PPO)
  • Cigna HMO
  • Cigna National POS Open Access
  • Cigna OAP
  • Cigna PPO
  • CompResults/CompAlliance (WC) PPO
  • Health Choice of Northwest Missouri (PPO)
  • Home State Health Plan Missouri Medicaid (Missouri practices)
  • Humana Choice PPO - Medicare Advantage
  • Humana ChoiceCare PPO
  • Humana Community HMO - Medicare Advantage
  • Humana Gold Choice Medicare Advantage PFFS
  • Humana Gold Plus HMO - Medicare Advantage
  • Humana Gold Plus HMO SNP - Medicare Advantage
  • Humana Kansas City PPOx
  • Humana National POS-Open Access Plans
  • Humana PPO
  • Humana Preferred PPO
  • Humana SmartExpress PPO
  • Humana SmartNet PPO
  • Humana SmartSuite PPO
  • HumanaOne PPO
  • Integrated Health Plan PPO
  • Kansas Medicaid
  • Medica Connect
  • Medica Select
  • Medicare
  • Missouri Care Health Plan - Missouri Medicaid (MO practices only)
  • MultiPlan/PCHS (PPO)
  • Occupational Health Management PPO (WC)
  • OHARA Managed Care (WC)
  • Private Healthcare Systems PPO
  • ProviDRs Care Network PPO (formerly WPPA)
  • Sunflower State Health Plan Kansas Medicaid (Kansas practices)
  • TRICARE WEST
  • Triwest Veterans Affairs Patient Centered Community Care
  • United Healthcare - All Savers Insurance Company POS
  • United Healthcare - Choice HMO
  • United Healthcare - Choice Plus POS
  • United Healthcare - Community Plan (KS Practices, KanCare, Kansas Medicaid)
  • United Healthcare - Community Plan (MO practices, Missouri Medicaid)
  • United Healthcare - Definity Health Reimbursement Account POS
  • United Healthcare - Definity Health Savings Account POS
  • United Healthcare - Golden Rule HMO (HMO & PPO)
  • United Healthcare - Indemnity
  • United Healthcare - Managed Indemnity
  • United Healthcare - Options PPO
  • United Healthcare - Select HMO
  • United Healthcare - Select Plus POS
  • United Healthcare - United Health One (Short Term Medical)
  • UnitedHealthcare - AARP Medicare Complete Choice PPO
  • UnitedHealthcare - AARP Medicare Complete HMO
  • UnitedHealthcare - AARP Medicare Complete PPO
  • UnitedHealthcare - Dual Complete SNP PPO
  • UnitedHealthcare - Group Medicare Advantage PPO
  • UnitedHealthcare - Medicare Complete PPO
  • UnitedHealthcare - Medicare Gold SNP PPO
  • UnitedHealthcare - Medicare Silver SNP PPO

Publications

Research Support (Co-PI: Dr. Meierotto)

Ongoing Research Support:R01 CA207445  (Behbod)
03/09/2017 - 02/28/2020

NIH
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS
Major Goals: The purpose of this grant application is to improve the MIND models by mimicking the natural microenvironment of human DCIS in mice. Our ultimate goal is to increase the translation application of the DCIS MIND models.

R01CA172764 (multi-PI: Cheng & Behbod)
09/01/2013 – 08/31/2018

NIH/NCI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling
Major Goals: To elucidate the role of CCR2/CCL2 signaling in DCIS progression to invasive breast cancer.
Role: Co-PI

RSG-13-182-01-CSM (Cheng)
07/01/2013 - 06/30/2017

Am Cancer Society
Barriers to Breast Cancer Treatment Due to CCL2/CCR2 Chemokine Signaling
Major Goals: To understand (1) the role of CCR2 expression in breast cancer progression using mouse models, and (2) the mechanisms of CCR2 signaling in breast cancer cell survival and invasion.
Role: Co-PI

R21 CA187890 (Behbod)
09/01/2014 - 08/31/2017

NIH
Elucidating Cellular Heterogeneity Among Cancer Stem Cells by Raman Spectroscopy
Major Goals: to evaluate the use of Raman Tweezer Spectroscopy for sorting and characterizing tumor initiating cells by the expression of unique intracellular molecular composition. This new technology is expected to enable further enrichment of the most aggressive tumor cells and facilitate the future design of anti-cancer therapies for their eradication.
Role: Co-PI

P30CA168524-suppl (Jensen)
03/03/2017 - 06/30/2017

NIH (suppl. to KU Cancer Center award)
MIND Models for Therapeutic Drug Testing Against Luminal B Breast Cancers
Major Goals: 1. To establish at least 5 unique ER+ MIND xenograft models by intraductal injection of epithelial cells derived from patients' luminal B breast cancer (HER2 negative) 2. To evaluate Ribociclib (LEE011; Novartis), a CDK4/6 inhibitor in combination with Letrozole, an aromatase inhibitor, in ER+ HER2 negative luminal B breast cancers.
Role: Co-PI

Recently Completed Research Support

R21CA185460 (Behbod)                                     
05/01/2014 - 04/30/2017

NIH/NCI
(no cost extension)
Essential Role of BCL9 in Promotion of Human DCIS to Invasive Ductal Carcinoma
Major Goals: To evaluate the role of nuclear vs. cytoplasmic BCL9 in promotion of DCIS invasive progression and in the formation of a DCIS pro-invasive stromal microenvironment by recruitment of macrophages.
Role: Co-PI

P30 GM11076102 (PI: Hanzlik)
08/01/2014 - 06/30/2019
NIH/National Institute of General Medical Sciences                                                                        

Project: Center of Biomedical Research Excellence in Protein Structure and Function
(Pilot Project PI: Behbod)
07/01/2015-06/30/2016

Subproject: Crystal Structure determination of STAT3/BCL9 Complex
Major Goals: to characterize binding interactions between BCL9 and STAT3 by x-ray crystallography and then use fragment screening to identify chemical compounds to interfere with this binding. The long-term goal is to find therapeutic strategies for prevention of breast cancer non-invasive to invasive progression.
Role:  Co-PI

R21CA187890 (Behbod)
08/26/2014 - 08/25/2016

NIH/NCI
Elucidating cellular heterogeneity among cancer stem cells by Raman Spectroscopy
Major Goals: To utilize Raman spectroscopy combined with flow cytometry in order to perform intracellular molecular profiling of cancer stem cells.
Role: Co-PI

No number (Behbod)
08/01/2014 - 07/30/2016

Breast Cancer Research Foundation - AACR Translational Breast Cancer Research
Essential Role of BCL9 in Promotion of Human DCIS to Invasive Ductal Carcinoma
Major Goals: 1) Evaluate BCL9 as a biomarker for DCIS with high risk of progression; 2) Evaluate the role of BCL9 in DCIS progression to invasion in animal models of disease; 3) Assess effects of pharmacologic inhibition of BCL9/β-catenin interaction on DCIS progression to IDC.
Role: Co-PI

Peer Reviewed Publications

  1. Lowe LH, Fernando S, Obaldo RE, et al. Duplicate Publication with Consequence of Potential Misinformation and Further Controversy. Pediatric radiology 2008; 38:839-840.
  2. Fernando S, Obaldo RE, Walsh IR, Lowe LH. Neuroimaging of Nonaccidental Head Trauma: Pitfalls and Controversies. Pediatric Radiology 2008; 38:827-838.                                                                                             
  3. Obaldo RE, Shao L, Lowe LH . Congenital Glioependymal Cyst Presenting with Severe Proptosis. American Journal of Neuroradiology 2007; 28:999-1000.

Educational Electronic/Poster Exhibits

  1. Hayley Hansford, Darlene Limback, Haleigh Harper, Yan Hong, Hanan Elsarraj, Lawrence R. Ricci, Fang Fan, Ossama Tawfik, Lisa May, Therese Cusick, Marc Inciardi, Mark Redick, Jason Gatewood, Onalisa Winblad, Tim Fields, Carol Fabian, Andrew K. Godwin, Ruby Meierotto, Fariba Behbod.  Mouse-Intraductal (MIND); The first in vivo model of human ductal carcinoma in situ (DCIS) invasive transition.  KUCC-Research Symposium. KU-Edwards Campus, Overland Park, KS, December 2017.
  2. Gill T, Al-Khalisi N, Stover JA, Massengale J, Smith WP, Meierotto RO, Saettele MR.  BI-RADS 3:  To Follow, or Not to Follow, That is the Question.  American Roentgen Ray Society Annual Meeting, May 2017
  3. Saettele MR , Adler KE, Tun M,  Lewis T,  Riaz MA, Meierotto RO.  BI-RADS: An Interactive Magnetic Resonance Imaging (MRI) Case Based Tutorial.  American Roentgen Ray Society Annual Meeting, May 2014
  4. Obaldo RE, Hovanessian-Laresn L, Palmer S, Sheth S, Sheth P. Pictorial Review of Extramammary Incidental Findings of Breast MRI. American Roentgen Ray Society Annual Meeting, April 2008
  5. Lowe LH, Obaldo RE, Fickenscher KA, Walsh I. Neuroimaging of Nonaccidental Trauma: Characteristic Findings, Pitfalls, and Controversies. Society for Pediatric Radiology, April 2007
  6. Obaldo RE, Morriss M C, Lowe L. Neuroimaging of Nonaccidental Trauma: Characteristic Findings, Pitfalls, and Controversies. American Roentgen Ray Society Annual Meeting, May 2006
  7. Obaldo RE, McCrary B S, Smith W P. Ultrasound Evaluation of Axillary Lymphnode Morphology following Breast Cancer Neoadjuvant Chemotherapy as a Marker for Treatment Response. American Roentgen Ray Society Annual Meeting, May 2006
  8. Wetzel L, Van Tasell C, Obaldo RE, Lemons S, Dusing R.  Combined PET/CT and Diagnostic CT Studies: Initial Experiences and Lessons Learned. Education Exhibit Radiological Society of North America Annual Meeting, Nov 2005
  9. Obaldo RE, Carruthers LM, Hansen JC  Linker Histone Dependent Stabilization of Chromatin Folding Education Exhibit Solution Interaction of Macromolecules Annual Meeting, 1998

Other Research Experience

ACR Case in Point: Bilateral Round Ligament Varicoceles
Verma R, Obaldo RE, Johnson M
USC Department of Radiology
September 29, 2008

UTHSCSA Radiology Department
The University of Texas Health Science Center Radiology Department has been studying the effectiveness, methodology, and complications of radiofrequency ablation as a treatment of hepatic malignancies.  I assisted in compiling data from 137 patients to investigate the complication of biliary dilatation after radiofrequency ablation treatment.
January 2001 – August 2001

UTHSCSA Radiology Department
I helped construct the body imaging teaching file by entering patient data information and digitalizing images (approximately 150 cases).
January 2001 – August 2001

On Staff At

  • Anderson County Hospital
  • Hedrick Medical Center
  • Saint Luke's Cushing Hospital
  • Saint Luke's East Hospital
  • Saint Luke's Hospital of Kansas City
  • Saint Luke's North Hospital–Barry Road
  • Saint Luke's North Hospital–Smithville
  • Saint Luke's South Hospital
  • Wright Memorial Hospital